Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

49
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
49
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Dementia01:30

Dementia

94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
94
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

440
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
440
Cognitivism01:17

Cognitivism

1.4K
Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Group-based compassionate mind training for low mood and anxiety in the menopause transition: a feasibility randomized controlled trial.

Menopause (New York, N.Y.)·2026
Same author

Cost utility and cost-effectiveness of the APPLE-Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce: economic evaluation embedded within a randomised controlled trial.

Age and ageing·2026
Same author

The limited diagnostic and prognostic utility of brief cognitive screening tools in acute stroke.

European stroke journal·2026
Same author

The effectiveness of psychosocial interventions on physiological symptoms of menopause: a systematic review and meta-analysis.

BMC women's health·2026
Same author

Effectiveness of interventions on cognitive decline risk for people living with HIV on antiretroviral therapy: a systematic review.

The lancet. Healthy longevity·2026
Same author

Mixed methods research to support the development of an evidence-based intervention for cognitive symptoms in menopause transition.

Menopause (New York, N.Y.)·2026

Related Experiment Video

Updated: Jun 2, 2025

Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

401

Cognitive stimulation to improve cognitive functioning in people with dementia.

Bob Woods1, Harleen Kaur Rai2, Emma Elliott3

  • 1Dementia Services Development Centre Wales, Bangor University, Bangor, UK.

The Cochrane Database of Systematic Reviews
|January 13, 2025
PubMed
Summary

Cognitive stimulation (CS) offers small, short-term cognitive benefits for individuals with mild to moderate dementia. This intervention also shows improvements in communication, social interaction, quality of life, and mood, with no reported negative effects.

More Related Videos

Transcranial Direct Current Stimulation tDCS for Memory Enhancement
10:37

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Published on: September 18, 2021

13.7K
Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum
11:47

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Published on: February 15, 2015

28.5K

Related Experiment Videos

Last Updated: Jun 2, 2025

Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

401
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
10:37

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Published on: September 18, 2021

13.7K
Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum
11:47

Modulating Cognition Using Transcranial Direct Current Stimulation of the Cerebellum

Published on: February 15, 2015

28.5K

Area of Science:

  • Gerontology and Dementia Care
  • Psychosocial Interventions
  • Evidence-Based Practice in Healthcare

Background:

  • Cognitive stimulation (CS) is a widely implemented intervention for dementia, involving enjoyable activities to enhance thinking, concentration, and memory.
  • CS differs from cognitive training/rehabilitation by its broad focus on quality of life (QoL) and mood, alongside cognitive function.
  • Existing guidelines recommend CS, but evidence on delivery modes and clinical significance requires systematic review.

Purpose of the Study:

  • To systematically evaluate the effectiveness of cognitive stimulation (CS) for people with dementia.
  • To assess impacts on cognition, quality of life, mood, and behavior, including any adverse effects.
  • To explore how different implementation methods influence CS outcomes.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs) of CS for dementia.
  • Searches conducted on Cochrane Dementia and Cognitive Improvement Group register and other databases up to March 2022.
  • Subgroup analyses performed based on intervention modality, frequency, setting, control type, and dementia severity.

Main Results:

  • 37 RCTs (2766 participants) were included, with moderate-quality evidence for small, short-term cognitive benefits (SMD 0.40).
  • Clinically relevant improvements observed in communication, social interaction (high-quality evidence), and QoL (moderate-quality evidence).
  • Cognitive benefits were larger with more frequent sessions (≥ twice weekly) and in mild dementia.

Conclusions:

  • Cognitive stimulation (CS) provides small, short-term cognitive benefits and improvements in communication, social interaction, QoL, and mood for people with mild to moderate dementia.
  • Further research is needed on individual CS, digital/remote delivery, multi-component programs, and long-term effects.
  • Session frequency and dementia severity appear to influence CS outcomes, warranting further investigation.